Ondine Biomedical Inc. (LON:OBI – Get Free Report) shares rose 26.8% during trading on Friday . The stock traded as high as GBX 6.50 ($0.08) and last traded at GBX 6.50 ($0.08). Approximately 490,817 shares changed hands during mid-day trading, an increase of 89% from the average daily volume of 259,447 shares. The stock had previously closed at GBX 5.13 ($0.06).
Ondine Biomedical Stock Up 28.8 %
The firm has a fifty day simple moving average of GBX 8.21 and a 200 day simple moving average of GBX 9.23. The company has a debt-to-equity ratio of 24.39, a quick ratio of 8.26 and a current ratio of 2.34. The company has a market cap of £14.97 million, a PE ratio of -110.00 and a beta of -0.15.
Ondine Biomedical Company Profile
Ondine Biomedical Inc, a Life sciences company, engages in the research, development, and commercialization of antimicrobial photodisinfection therapies in Canada and internationally. Its product platform is Photodisinfection, a topical light-based antimicrobial technology that eliminates harmful pathogens.
Read More
- Five stocks we like better than Ondine Biomedical
- Stock Analyst Ratings and Canadian Analyst Ratings
- MarketBeat Week in Review – 4/29 – 5/3
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- Apple’s Earnings Show Investors Its Strength and Its Weakness
- Buy P&G Now, Before It Sets A New All-Time High
- Bargain Alert: 3 Large Caps With Extremely Oversold RSIs
Receive News & Ratings for Ondine Biomedical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ondine Biomedical and related companies with MarketBeat.com's FREE daily email newsletter.
